Previous 10 | Next 10 |
MINNEAPOLIS, April 27, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announce...
Inspire Medical Systems (NYSE: INSP) has a new device for treating sleep apnea. This is a condition where a person stops breathing during their sleep, and their body shocks them awake. Sleep apnea is a serious risk factor for cardiovascular disease -- the leading cause of death for ...
MINNEAPOLIS, April 05, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (“Inspire”), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today an...
Executive Chair Bill Ford picked up $4.5 million worth of Ford stock on the open market last week. Automotive part manufacturer LCI Industries saw a cluster of three insiders purchase shares. Insiders are buying ahead of an earnings related blackout period. For further detai...
Vivos Therapeutics, Inc. markets a jaw repositioning device that has the potential to cure patients’ mild-to-moderate obstructive sleep apnea. Despite an active 2021 that saw its mmRNA oral appliance cleared as a Level II device – prompting gains in insurance coverage (i...
So far, 2022 has been pretty brutal on the market. Rising interest rates, the invasion of the Ukraine, and COVID-19 caused a bear rampage in the first two months of 2022. But you can always find some winners, even in bad markets. That's particularly true in healthcare, always a strong defen...
Inspire Medical Systems, Inc. (INSP) Q4 2021 Earnings Conference Call February 8, 2022 05:00 p.m. ET Company Representatives Tim Herbert - President, Chief Executive Officer Rick Buchholz - Chief Financial Officer Megan Rowekamp - Director of Financial Reporting Conference Call Participants R...
Inspire Medical Systems press release (NYSE:INSP): Q4 GAAP EPS of -$0.09 beats by $0.33. Revenue of $78.4M (+70.4% Y/Y) beats by $2.8M. Inspire expects full year 2022 revenue to be in the range of $318 million to $326 million, which would represent growth of approximately 36% to 40%...
MINNEAPOLIS, Feb. 08, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) ("Inspire"), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, today reported financia...
MINNEAPOLIS, Feb. 07, 2022 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative and minimally invasive solutions for patients with obstructive sleep apnea, announced today that i...
News, Short Squeeze, Breakout and More Instantly...
Inspire Medical Systems Inc. Company Name:
INSP Stock Symbol:
NYSE Market:
Inspire Medical Systems Inc. Website:
A look at the top 10 most actives in the United States Selina Hospitality PLC (SLNA) fell 20.2% to $0.03 on volume of 382,247,953 shares BurgerFi International Inc (BFI) rose 97.3% to $0.4205 on volume of 313,737,613 shares NVIDIA Corporation (NVDA) rose 0.7% to $113.06 on volume of 292,060...
MINNEAPOLIS, July 23, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea (OSA), announced today the publi...
MINNEAPOLIS, July 22, 2024 (GLOBE NEWSWIRE) -- Inspire Medical Systems, Inc. (NYSE: INSP) (Inspire), a medical technology company focused on the development and commercialization of innovative, minimally invasive solutions for patients with obstructive sleep apnea, announced today the addition of...